Spangenberg, C; Lausch, EU; Trost, TM et al.
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditionsCancer Res. Bd. 66. 2006 S. 3715-3725
Carmo, H; Brulport, M; Hermes, M et al.
Influence of CYP2D6 polymorhpism on 3,4-methylenedioxymethamphetamine (Ecstasy) cytotoxicityPharmacogenet Genomics. 2006 S. 789-799
Fritz, G; Kaina, B
Late activation of stress kinases (SAPK/JNK) by genotoxins requires the DNA repair proteins DNA-Pkcs and CSBMol Cell Biol. Bd. 17. 2006 S. 851-861
Nubel, T; Damrot, J; Roos, WP et al.
Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.Clin Cancer Res. Bd. 12. H. 3 Pt 1. 2006 S. 933-9
Damrot, J; Nubel, T; Epe, B et al.
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.Br J Pharmacol. Bd. 149. H. 8. 2006 S. 988-97
Hermisson, M; Klumpp, A; Wick, W et al.
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.J Neurochem. Bd. 96. H. 3. 2006 S. 766-76
Kaina, B; Christmann, M
O6-Methylguanine-dNA methyltransferases (alkyltransferases)Ganten (Hrsg). Encyclopedic Reference of Genomic and Proteomics in Molecular Medicine. Springer-Verlag 2006
Hengstler, J. G.; Bockamp, E. O.; Hermes, M. et al.
Oneogene-blocking therapies: New insights from conditional mouse tumor modelsCURRENT CANCER DRUG TARGETS. Bd. 6. H. 7. 2006 S. 603-612
McGurk, CJ; Cummings, M; Koberle, B et al.
Regulation of DNA repair gene expression in human cancer cell lines.J Cell Biochem. Bd. 97. H. 5. 2006 S. 1121-36
Fritz, G; Kaina, B
Rho GTPases: promising cellular targets for novel anticancer drugs.Curr Cancer Drug Targets. Bd. 6. H. 1. 2006 S. 1-14